Statistical optimization and characterization of pH-independent extended-release drug delivery of cefpodoxime proxetil using Box-Behnken design

Chemical Engineering Research and Design

Volumn 92, Issue 1, 2014, Pages 156-165

  Mujtaba, Ali ^a   Ali, Mushir ^a   Kohli, Kanchan ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Box Behnken design; Cefpodoxime proxetil; Extended release; Optimization

Indexed keywords

BOX-BEHNKEN DESIGN; BOX-BEHNKEN EXPERIMENTAL DESIGN; CEFPODOXIME PROXETIL; EXTENDED-RELEASE; HYDROXYPROPYL METHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; MULTIPLE RESPONSE OPTIMIZATION; RESPONSE SURFACE METHODOLOGY;

DESIGN; DRUG DELIVERY; POLYNOMIALS; SURFACE PROPERTIES;

OPTIMIZATION;

EID: 84892804907     PISSN: 02638762     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cherd.2013.05.032     Document Type: Article

References (38)

1. Borin M.T. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs 1991, 42(Suppl. 3):13-21.
2. Box G.E.P., Behnken D.W. Some new three level designs for the study of quantitative variables. Technometrics 1960, 2:455-475.
3. Cressman W., Summer D. The dog as a quantitative model for evaluation of nondisintegrating sustained-release tablets. J. Pharm. Sci. 1971, 60:132-134.
4. Dayal P., Pillay V., Babu R.J., Singh M. Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size and dynamic surface tension. AAPS PharmSciTech 2005, 6:E573-E585.
5. Durig T., Fassihi R. Guar-based monolithic matrix systems: effect of ionisable and non-ionisable substances and excipients on gel dynamics and release kinetics. J. Control. Release 2002, 80:45-56.
6. Eddington N.D., Ashraf M., Augsburger L.L., Leslie J.L., et al. Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavialability of propranolol hydrochloride tablets. Pharm. Dev. Technol. 1998, 3:535-547.
7. Efentakis M., Koutlis A. Release of furosemide from multiple unit and single unit preparations containing different viscosity grades of sodium alginate. Pharm. Dev. Technol. 2001, 6:91-98.
8. Feely L.C., Davis S.S. Influence of surfactants on the drug release from hydroxypropylmethylcellulose. Int. J. Pharm. 1988, 41:83-90.
9. Ford J.L., Rubinstein M.H., Hogan J.E. Formation of sustained release promethazine hydrochloride tablets using hydroxypropylmethylcellulose matrix. Int. J. Pharm. 1985, 24:327-338.
10. Govender S., Pillay V., Chetty D.J., Essack S.Y., Dangor C.M., Govender T. Optimization and characterization of bioadhesive controlled release tetracycline microspheres. Int. J. Pharm. 2005, 306:24-40.
11. Hamed E., Sakr A. Application of multiple response optimization technique to extended release formulations design. J. Control. Release 2001, 73:329-338.
12. Heng P.W., Chan L.W., Easterbrook M.G. Investigation of the influence of mean HPMC particle size on the release of aspirin from swellable hydrophilic matrix tablets. J. Control. Release 2001, 76:39-49.
13. Howard J.R., Timmins P. Controlled Release Formulations 1988, US Patent 4,792,452.
14. Huang Y.B., Tsai Y.H., Lee S.H., Chang J.S., Wu P.C. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int. J. Pharm. 2005, 289:87-95.
15. Huang Y.B., Tsai Y.H., Yang W.C., Chang J.S., Wu P.C., Takayama K. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm. 2004, 58(3):607-614.
16. Kakumanu V.K., Arora V.K., Bansal A.K. Gastro-retentive dosage form for improving bioavailability of Cefpodoxime proxetil in rats. Yakugaku Zasshi 2008, 128(3):439-445.
17. Katori N., Okudaria K., Aoyagi N., Takeda Y., Uchiyama M. In vitro and in vivo correlation for controlled-release formulation of dchlorpheniramine maleate. J. Pharmacobiodyn. 1991, 14:567-575.
18. Khan M.A., Karnachi A.A., Singh S.K., Sastry S.V., Kislalioglu S.M., Bolton S. Controlled release coprecipitates: formulation considerations. J. Control. Release 1995, 37:132-141.
19. Kim M.S., Kim J.S., You Y.H., Park H.J., Lee S., Park J.S., et al. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology. Int. J. Pharm. 2007, 341:97-104.
20. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35.
21. Lahdenpaa E., Niskanen M., Yliruusi J. Crushing strength disintegration time and weight variation of tablets compressed from three MCC pH grades and their mixtures. Eur. J. Pharm. Biopharm. 1997, 42:315-322.
22. Li J.Z., Rekhi G.S., Augsburger L.L., Shangraw R.F. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution. Pharm. Dev. Technol. 1996, 1:343-355.
23. Mockel J.E., Lippold B.C. Zero order release from hydrocolloid matrices. Pharm. Res. 1993, 10:1066-1070.
24. Myers R.H., Montgomery D.C. Response Surface Methodology: Process and Product Optimization Using Designed Experiments 2002, 273-286. John Wiley & Sons, New York.
25. Nokhodchi A., Norouzi-Sani S., Siahi-Shadbad M.R., Lotfipoor M. The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-Eudragit matrix. Eur. J. Pharm. Sci. 2002, 54:349-356.
26. Nutan M.T.H., Soliman M.S., Taha E.I., Khan M.A. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate. Int. J. Pharm. 2005, 294:89-101.
27. Palamakula A., Nutan M.T.H., Khan M.A. Response surface methodology for optimization and characterization of limonene based coenzyme Q10 self-nanoemulsified capsule dosage form. APPS PharmSciTech 2004, 5:1-8.
28. Ragonese R., Macka M., Hughes J., Petocz P. The use of the Box-Behnken experimental design in the optimization and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. J. Pharm. Biomed. Anal. 2002, 27:995-1007.
29. Sako K., Sawada T., Nakashima H., Yokohama S., Sonobe T. Influence of water soluble fillers on hydroxypropylmethylcellulose matrix on in vitro and in vivo drug release. J. Control. Release 2002, 81:165-172.
30. Segurola J., Allen N.S., Edge M., McMahon A. Design of eutectic photoinitiator blends for UV/visible curable acrylated printing inks and coatings. Prog. Org. Coat. 1999, 37:23-37.
31. Seo S., Choi H.S., Khang G., Rhee J.M., Lee H.B. A local delivery system for fentanyl based on biodegradable poly (l-lactide-co-glycolide) oligomer. Int. J. Pharm. 2002, 239:93-101.
32. Singh B., Chakkal S.K., Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech 2006, 7:E1-E9.
33. Timmins P., Delargy A.M., Howard J.R. Optimization and characterization of a pH independent extended release by hydrophilic matrix tablet. Pharm. Dev. Technol. 1997, 2:25-31.
34. Tønnesen H.H., Karlsen J. Alginate in drug delivery systems. Drug Dev. Ind. Pharm. 2002, 28(6):621-630.
35. Uchida T., Kawata M., Goto S. In vivo evalution of ethyl cellulose microcapsules containing amipicillin using rabbits, dogs and humans. J. Pharmacobiodyn. 1986, 9:631-637.
36. USP XXIII. United State Pharmacopeial Convention, Inc., Rockville, MD, 1995. 1328.
37. Vlachou M., Hani N., Efentakis M., Tarantili P.A., Andreopoulos A.G. Polymers for use in controlled release system: the effect of surfactants on their swelling properties. J. Biomater. Appl. 2000, 15:65-77.
38. Zuleger S., Lippold B.C. Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. Int. J. Pharm. 2001, 217:139-152.